If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
300.00    -1.00 (-0.33%)
Bid:
298.00
Ask:
300.00
Spread: 2.00 (0.671%)
Market Cap: £267.68m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Holding(s) in Company

6 Jul 2012 12:53

RNS Number : 1232H
Norcros PLC
06 July 2012
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Norcros PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 

 Artemis Investment Management LLP on behalf of discretionary funds under management

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

 04 July 2012

6. Date on which issuer notified:

 

 05 July 2012

7. Threshold(s) that is/are crossed or reached:

 

 10%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B1Y9V062

 

57,448,635

 57,448,635

 59,133,460

 59,133,460

 10.20%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 59,133,460

 10.20%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

Richard Smithson

15. Contact telephone number:

 

0207 399 6063

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBKADPDBKDBOK
Date   Source Headline
3rd Jul 20263:30 pmRNSTotal Voting Rights
22nd Jun 20264:32 pmRNSAnnual Report & Accounts / Notice of AGM
11th Jun 20267:00 amRNSResults for the 53 weeks ended 5 April 2026
21st May 20267:00 amRNS-RInvestor Presentation Webinar on 18 June 2026
12th May 20267:00 amRNSStrategic update: South African operations
30th Apr 202611:42 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSYear-end Trading and Board update
2nd Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSBlock Listing Six Monthly Return
3rd Mar 20269:29 amRNSDirectors Share Dealing - correction
3rd Mar 20267:00 amRNSDirectors Share Dealing
2nd Feb 20267:00 amRNSAppointment of Joint Corporate Broker
14th Jan 202612:12 pmRNSDirectors Share Dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
28th Nov 20254:03 pmRNSHolding(s) in Company
20th Nov 20256:22 pmRNSDirectors Share Dealing
20th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNS-RInvestor Presentation Webinar on 1 December 2025
21st Oct 20255:04 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSTrading update
13th Oct 20257:24 amRNSCompletion of Acquisition of Fibo Holding AS
30th Sep 202511:46 amRNSBlock Listing Six Monthly Return
23rd Jul 202512:03 pmRNSDirector Dealings - APSP and DBP Share Options
23rd Jul 202511:59 amRNSResults of AGM
23rd Jul 20257:11 amRNSAGM Trading Statement
21st Jul 20254:11 pmRNSDirector Dealings - DBP Share Option exercises
16th Jul 20255:01 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSAcquisition of Fibo Holding AS
23rd Jun 20257:00 amRNSJTSA Outcome of Strategic Review
20th Jun 20254:10 pmRNSAnnual Financial Report and Notice of 2025 AGM
12th Jun 20257:00 amRNSResults for the year ended 31 March 2025
3rd Jun 20257:00 amRNS-RInvestor Webinar
10th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
31st Mar 20257:00 amRNSBlock Listing 6 Monthly Return
31st Mar 20257:00 amRNSTotal Voting Rights
13th Mar 20257:00 amRNSPension Scheme Valuation Update
5th Feb 20253:45 pmRNSDirectors Share Dealing
31st Dec 20247:00 amRNSVoting Rights and Share Capital Update
10th Dec 202411:49 amRNSHolding(s) in Company
6th Dec 202411:52 amRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSTotal Voting Rights
21st Nov 20245:01 pmRNSHolding(s) in Company
21st Nov 202411:57 amRNSInterim Results - Replacement
21st Nov 20247:00 amRNSResults for the six months ended 30 September 2024
1st Nov 20247:00 amRNSTotal Voting Rights
10th Oct 20247:00 amRNSTrading update
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 202410:08 amRNSBlock listing Six Monthly Return
30th Aug 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.